{
  "book_page": 122,
  "pdf_page": 62,
  "content": {
    "main_concept": "Cholestyramine (Questran) lowers low-density lipoprotein (LDL) levels",
    "key_points": "- **Cholestyramine (Questran) is an antihyperlipidemic agent and bile acid sequestrant**\\n- **Common side effects include**: \\n  - **C**onstipation\\n  - **A**bdominal cramps\\n  - **B**ackache\\n  - **W**eakness and muscle pain\\n  - **E**xacerbation of hemorrhoids\\n  - **B**leeding\\n  - **S**kin irritation\\n- **Take the drug before meals**\\n- **Mix one packet or one scoop with water, milk, juice, soup or cereals**",
    "questions": [
      {
        "id": 1,
        "type": "multiple_choice",
        "question_text": "Which of the following is an expected outcome for a client receiving cholestyramine (Questran)?",
        "options": [
          "1. Decreased blood pressure",
          "2. Decreased urine output",
          "3. Decreased serum cholesterol",
          "4. Decreased respiratory rate"
        ],
        "correct_answer": "3",
        "rationale": "**RATIONALE**\\n\\nCholestyramine (Questran) is an anti-hyperlipidemic agent. Therefore, an expected outcome is decreased serum cholesterol."
      }
    ]
  },
  "images": [],
  "extraction_metadata": {
    "timestamp": "2025-09-18T02:58:18Z",
    "extraction_confidence": "high",
    "human_validated": false,
    "notes": "Complete concept extracted from left side of PDF page 62",
    "category": "Pharmacological and Parenteral Therapies",
    "reference": "Karch, Amy, Lippincott's Nursing Drug Guide Philadelphia, Lippincott Williams and Wilkins"
  }
}